New Delhi, Sept. 2 -- Park Medi World is entering a new phase of growth, according to Ventura Securities, which has reiterated its Buy rating and sharply raised its target price to Rs.406 from its earlier target of Rs.284. At the current market price of Rs.286, the revised target implies an upside potential of 41.9% over a 24-month horizon.

Ventura Securities believes the company's execution has remained robust since the brokerage initiated coverage. Faster-than-expected bed additions are positioning Park Medi World to achieve its FY28 capacity target ahead of schedule, while healthy occupancy levels could support both further expansion and margin improvement.

"Since then, execution has remained strong, with accelerated bed additions po...